OBJECTIVE: To determine whether the diuretic and natriuretic effects of low-dose dopamine (2.5 micrograms/kg/min) are associated with changes in serum aldosterone concentration. DESIGN: Prospective clinical study. SETTING: Surgical intensive care unit (SICU) of a university hospital. PARTICIPANTS: Oliguric (urine output < 0.5 mL/kg/h) SICU patients. All patients were resuscitated to pulmonary artery occlusion pressure > 10 mm Hg, mean arterial pressure > 65 mm Hg, and cardiac index > 2.5 L/min/m2. Patients with a serum creatinine concentration > 176.8 mumol/L (2.0 mg/dL), those who received diuretics within 12 hours prior to entry into the study, and renal transplant recipients were excluded. MAIN OUTCOME MEASURES: Hourly urine output (mean +/- SD) was recorded 2 hours before and for 6 hours after the initiation of low-dose dopamine. Urine sodium and serum aldosterone concentrations were obtained prior to and 6 hours after the start of low-dose dopamine. RESULTS: Fifteen patients were enrolled in the study. Urine output (mean +/- SD) increased from 0.31 +/- 0.11 mL/kg/h before to 0.80 +/- 0.34 mL/kg/h following low-dose dopamine (p < 0.01). Urine sodium concentrations increased from 46 +/- 32 mmol/L baseline to 72 +/- 53 mmol/L following low-dose dopamine (p < 0.05), and serum aldosterone concentrations decreased from 415.82 +/- 341.48 pmol/L prior to low-dose dopamine infusion to 256.04 +/- 204.17 pmol/L (p < 0.05). Cardiac output, pulmonary artery occlusion pressure, mean arterial pressure, and heart rate did not change. CONCLUSIONS: Low-dose dopamine significantly increases urine output and urine sodium excretion in oliguric, critically ill, surgical patients, and is associated with a decrease in serum aldosterone concentration. The diuretic and natriuretic effects of low-dose dopamine may be, in part, related to a dopamine-mediated inhibition of aldosterone secretion.
OBJECTIVE: To determine whether the diuretic and natriuretic effects of low-dose dopamine (2.5 micrograms/kg/min) are associated with changes in serum aldosterone concentration. DESIGN: Prospective clinical study. SETTING: Surgical intensive care unit (SICU) of a university hospital. PARTICIPANTS: Oliguric (urine output < 0.5 mL/kg/h) SICU patients. All patients were resuscitated to pulmonary artery occlusion pressure > 10 mm Hg, mean arterial pressure > 65 mm Hg, and cardiac index > 2.5 L/min/m2. Patients with a serum creatinine concentration > 176.8 mumol/L (2.0 mg/dL), those who received diuretics within 12 hours prior to entry into the study, and renal transplant recipients were excluded. MAIN OUTCOME MEASURES: Hourly urine output (mean +/- SD) was recorded 2 hours before and for 6 hours after the initiation of low-dose dopamine. Urine sodium and serum aldosterone concentrations were obtained prior to and 6 hours after the start of low-dose dopamine. RESULTS: Fifteen patients were enrolled in the study. Urine output (mean +/- SD) increased from 0.31 +/- 0.11 mL/kg/h before to 0.80 +/- 0.34 mL/kg/h following low-dose dopamine (p < 0.01). Urine sodium concentrations increased from 46 +/- 32 mmol/L baseline to 72 +/- 53 mmol/L following low-dose dopamine (p < 0.05), and serum aldosterone concentrations decreased from 415.82 +/- 341.48 pmol/L prior to low-dose dopamine infusion to 256.04 +/- 204.17 pmol/L (p < 0.05). Cardiac output, pulmonary artery occlusion pressure, mean arterial pressure, and heart rate did not change. CONCLUSIONS: Low-dose dopamine significantly increases urine output and urine sodium excretion in oliguric, critically ill, surgical patients, and is associated with a decrease in serum aldosterone concentration. The diuretic and natriuretic effects of low-dose dopamine may be, in part, related to a dopamine-mediated inhibition of aldosterone secretion.